Glimimark M1 Tablet 15 is used to manage type 2 diabetes mellitus. It combines glimepiride (sulfonylurea) and metformin (biguanide). Glimepiride stimulates insulin release, while metformin reduces glucose production in the liver and improves insulin sensitivity. It is prescribed when diabetes cannot be managed by a single medication, aiding in reducing both fasting and post-meal blood glucose levels.




















